CIK 0001130166 · Non-accelerated filer<br>Smaller reporting company
Bio Green Med Solution, Inc.
Sign in to watch- Tickers
- BGMS BGMSP
- Exchange
- Nasdaq, OTC
- Industry
- Wholesale-Durable Goods, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 911766850
- Phone
- 908-517-7330
- Business address
- 200 CONNELL DRIVE, SUITE 1500, BERKELEY HEIGHTS, NJ, 07922
- Former names
- Cyclacel Pharmaceuticals, Inc., XCYTE THERAPIES INC
Securities
- BGMS Common Stock Nasdaq
- BGMSP Common stock OTC
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale 10% owner sold 54,900 shares at an average $1.85 ($101,628)
- 4 Open-market buy 10% owner bought 34,600 shares at $1.91 ($66,086)
- 4 Open-market buy V.P., Clin. Dev. & Reg. Aff. bought 2,000 shares at an average $2.14 ($4,272)
- 4 Open-market buy Director bought 5,000 shares at an average $1.93 ($9,659)
- 4 Open-market buy President & C.E.O. bought 10,000 shares at an average $2.03 ($20,270)
- 4 Open-market buy 10% owner bought 23,900 shares at $2.09 ($49,951)
- 4 Open-market buy E.V.P., Finance & C.O.O. bought 1,950 shares at $2.25 ($4,388)
- 4 Open-market buy President & C.E.O. bought 12,500 shares at an average $2.32 ($28,990)
- 4 Open-market buy President & C.E.O. bought 15,000 shares at an average $2.59 ($38,780)
- 10-Q Report Quarterly Report
- 4 Open-market sale 10% owner sold 1,600 shares at $2.84 ($4,544)
- 4 Open-market sale 10% owner sold 66,700 shares at an average $2.94 ($195,978)
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- DEF 14A Proxy Proxy Statement
- 8-K Event Executive or director change
- 4 Open-market sale 10% owner sold 38,900 shares at $3.09 ($120,201)
Page 56 of 76 · 1,511 filings